CHRNA7 and neoplasm: Proliferation of tumor cells was also reduced after both cycles of APS treatment; however, in the tumors that regrew after the second cycle, the fraction of proliferating cells increased again, which indicated the loss of APS8 inhibitory effects on the α7 nAChR signaling pathway in certain percentage of tumors.